Clinical evaluation of the effect of AYNKAAYA CHOORANAM for the treatment of Indigestion associated constipation in childre
Phase 2
Completed
- Conditions
- Health Condition 1: K318- Other specified diseases of stomach and duodenum
- Registration Number
- CTRI/2020/01/022916
- Lead Sponsor
- B Radha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Abdominal pain
Abdominal distension
Constipation
Oliguria
Anorexia
Low grade fever
Consumption of less milk, food, and feeling of fullness of stomach
Tiredness
Exclusion Criteria
Anal fissure
Anal stricture
Intestinal parasitosis
Intestinal obstruction
Rectal bleeding
Intussuseption
Hyperpaeristalsis condition
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Peristaltic movements <br/ ><br>Number of defecation per dayTimepoint: 3 - 5 days
- Secondary Outcome Measures
Name Time Method bowel movement that are hard <br/ ><br>dry and difficult to pass stoolsTimepoint: 7 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie AYNKAAYA CHOORANAM's efficacy in treating indigestion-associated constipation in children?
How does AYNKAAYA CHOORANAM compare to standard-of-care treatments for pediatric constipation in clinical outcomes?
Are there specific biomarkers that can predict patient response to AYNKAAYA CHOORANAM in K318-related gastrointestinal disorders?
What are the potential adverse events associated with AYNKAAYA CHOORANAM in children and how can they be managed?
What are the related compounds or combination therapies that could enhance AYNKAAYA CHOORANAM's effectiveness in treating KATTU MAANTHAM?